Tiantian Cui MD, PhD
@cui_tiantian
ID: 1463571797274546180
24-11-2021 18:14:59
16 Tweet
7 Followers
11 Following
Congratulations to Tiantian Cui MD, PhD for leading rigorous work on our novel albumin-gemcitabine prodrug JNTX-101, now published in Molecular Therapy Oncolytics, that she previously presented at AACR. ASGCT AACR City of Hope sciencedirect.com/science/articl…
Here, Terry Williams discusses the potential of #SCINTIX PET-guided #BgRT to address unmet need in the future and bringing more biology to the treatment of cancer in #radonc. City of Hope bit.ly/48r0Rji
Congrats to Adam Wolfe, MD, PhD, Tiantian Cui MD, PhD, and the rest of the stellar team for the Science Advances publication on nutrient scavenging in #pancreaticcancer. 👏 The work uncovers a pivotal role for caveolae-mediated endocytosis (CME) in fueling #PDAC growth. #pancsm #gism
2/n In this report, CAV1 is found to be associated with the most aggressive molecular subtypes of #PDAC, including basal-like, quasi-mesenchymal, and squamous using the Moffitt, Collisson, and Bailey schemes. PanCAN Lustgarten Foundation Anirban Maitra
5/n We developed the first conditional knockout mouse model of CAV1, and genetic of Cav-1 in this GEMM in the #KRAS KPC mouse model significantly attenuated #PDAC growth and reduced tumor burden. KRASKickers
.Simon Powell, Meredith Morgan, Tiantian Cui, and Gaorav Gupta discussed "Integrating DNA Damage Repair Targeting with Radiation Therapy" in a plenary at the AACR Conference on Translating Targeted Therapies in Combination with Radiotherapy. #AACRradiation25 Gaorav Gupta
What a fantastic #AACRRadiation25 conference in San Diego with a stellar lineup including our own Tiantian Cui MD, PhD and Dr. Ghomalin. 🙏 to Quynh Thu Le Albert Koong, MD PhD & Silvia Formenti for putting together a great session to discuss where the future of RadOnc needs to go.#radbio